StockData
Sinovac Biotech Ltd logo

Sinovac Biotech Ltd (SVA) stock

SVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 5, 2026Score 7/30
$6.47+0.00 (0.00%)

Close on Nov 17, 2026Market cap $464.94MP/E –Yield 850.08%

Sinovac Biotech operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -$512.18M. The highest annual figure on record is $15.32B in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$512.18M–
FY2024Dec 31, 2024-$56.89M-141.0%
FY2023Dec 31, 2023$138.65M–
FY2022Dec 31, 2022-$798.12M-105.2%
FY2021Dec 31, 2021$15.32B+3096.7%
FY2020Dec 31, 2020$479.31M+1126.7%
FY2019Dec 31, 2019$39.07M+391.9%
FY2018Dec 31, 2018$7.94M-86.7%
FY2017Dec 31, 2017$59.76M–
FY2016Dec 31, 2016-$13.90M-430.1%
FY2015Dec 31, 2015$4.21M–
FY2014Dec 31, 2014-$10.13M-281.6%
FY2013Dec 31, 2013$5.58M–
FY2012Dec 31, 2012-$16.25M-216.6%
FY2011Dec 31, 2011$13.94M–
FY2010Dec 31, 2010-$14.28M-129.5%
FY2009Dec 31, 2009$48.41M–

More Sinovac Biotech figures

See a number that looks wrong?